DP
DCI Partners
Venture CapitalModerateDCI Partners is a venture capital firm specializing in the fields of drug discovery and regenerative medicine.
8
Investments
1
Exits
—
AUM
12.5%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for DCI Partners.
Investment Thesis & Strategy
DCI Partners invests in various stages of fintech companies, seeking to support innovative solutions within the financial technology sector.
Investment Activity
Deals per year over the last 10 years
1
20071
20080
20090
20101
20110
20121
20130
20140
20151
2016Portfolio Companies
Selected investments from their portfolio of 8 companies
R
Rgenix
Biotech · Series A, 2016
A
Aeglea BioTherapeutics
Biotech · Series A, 2013
D
DiscGenetics
Biotech · Series A, 2011
V
Vascular Biogenics
Biotech · Series A, 2008
R
Reata Pharmaceuticals
Biotech · Series A, 2007
Frequently Asked Questions
DCI Partners focuses on Series A, Series B, Series C+ stage investments.